Ritholtz Wealth Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Ritholtz Wealth Management's UTHR Position: Q3 2026 in Review
Ritholtz Wealth Management increased its United Therapeutics (UTHR) stake by 33% in Q3 2026, buying an estimated $326K and bringing the position to 2,536 shares worth $1.37M. The position accounts for 0.02% of the portfolio, ranked #551.
Ritholtz Wealth Management first reported a position in UTHR in Q1 2021 and has held it in 18 quarters since. 428 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Ritholtz Wealth Management held 2,536 shares of United Therapeutics worth $1.37M as of Q3 2026.
- Ritholtz Wealth Management bought 631 United Therapeutics shares in Q3 2026, an estimated $326K.
- United Therapeutics made up 0.02% of Ritholtz Wealth Management's portfolio in Q3 2026, its #551 holding.
- Ritholtz Wealth Management first reported a position in United Therapeutics in Q1 2021 and has held it in 18 quarters since.
- 428 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Ritholtz Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.